Plasma cell characteristics predict benefit from intensified therapy in AL amyloidosis

被引：0
|
作者：
Steinhardt, Maximilian [1 ,2 ,3 ]
Oubari, Sara [4 ]
Cejka, Vladimir [1 ]
Morbach, Caroline [5 ]
Papagianni, Aikaterini [5 ]
Sommer, Claudia [5 ]
Stoerk, Stefan [5 ]
Einsele, Hermann [5 ]
Carpinteiro, Alexander [4 ]
Kortuem, Martin [5 ]
机构：
[1] Julius Maximilians Univ Wurzburg, Wurzburg, Germany
[2] Univ Hosp Wurzburg, Interdisciplinary Amyloidosis Ctr Northern Bavari, Wurzburg, Germany
[3] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[4] Univ Duisburg Essen, Essen, Germany
[5] Univ Hosp Wurzburg, Wurzburg, Germany
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
235
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [41] Persisting Cardiac Dysfunction and Quality of Response Predict Survival in Patients with AL Amyloidosis Who Respond to Upfront Therapy
    Palladini, Giovanni
    Milani, Paolo
    Basset, Marco
    Russo, Francesca
    Foli, Andrea
    Merlini, Giampaolo
    BLOOD, 2017, 130
  • [42] Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: Results from the Intergroup Rhabdomyosarcoma Study IV
    Baker, KS
    Anderson, JR
    Link, MP
    Grier, HE
    Qualman, SJ
    Maurer, HM
    Breneman, JC
    Wiener, ES
    Crist, WM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) : 2427 - 2434
  • [43] Pathogenetic associations of plasma cell cyclin D1 overexpression in systemic AL amyloidosis
    Zhou, P.
    Iyer, L. K.
    Hassoun, H.
    Hoffman, J.
    Landau, H.
    Comenzo, R. L.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 197 - 197
  • [44] The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients
    Perfetti, V
    Vignarelli, MC
    Anesi, E
    Garini, P
    Quaglini, S
    Ascari, E
    Merlini, G
    HAEMATOLOGICA, 1999, 84 (03) : 218 - 221
  • [45] Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
    Martin Lauss
    Marco Donia
    Katja Harbst
    Rikke Andersen
    Shamik Mitra
    Frida Rosengren
    Maryem Salim
    Johan Vallon-Christersson
    Therese Törngren
    Anders Kvist
    Markus Ringnér
    Inge Marie Svane
    Göran Jönsson
    Nature Communications, 8
  • [46] Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
    Lauss, Martin
    Donia, Marco
    Harbst, Katja
    Andersen, Rikke
    Mitra, Shamik
    Rosengren, Frida
    Salim, Maryem
    Vallon-Christersson, Johan
    Torngren, Therese
    Kvist, Anders
    Ringner, Markus
    Svane, Inge Marie
    Jonsson, Goran
    NATURE COMMUNICATIONS, 2017, 8
  • [47] Characteristics of breast cancer patients unlikely to benefit from adjuvant therapy
    Ejlertsen, B.
    Christiansen, P.
    Bjerre, K.
    Jensen, M. B.
    Rasmussen, B. B.
    Laenkholm, A. V.
    Kroman, N.
    Kvistgaard, M. E.
    Offersen, B.
    Toftdahl, D. B.
    Moller, S.
    Mouridsen, H. T.
    BREAST, 2011, 20 : S14 - S14
  • [48] AL Amyloidosis - Pathogenesis and Prognosis Are Determined By the Amyloidogenic Potential of the Light Chain and the Molecular Characteristics of Malignant Plasma Cells
    Seckinger, Anja
    Hegenbart, Ute
    Beck, Susanne
    Emde, Martina
    Bochtler, Tilmann
    Kimmich, Christoph
    Muller-Tidow, Carsten
    Jauch, Anna
    Schoenland, Stefan
    Hose, Dirk
    BLOOD, 2018, 132
  • [49] Monoclonal antibodies in the treatment of AL amyloidosis: co-targetting the plasma cell clone and amyloid deposits
    Popkova, Tereza
    Hajek, Roman
    Jelinek, Tomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (02) : 228 - 238
  • [50] Bone marrow plasma cells and immune microenvironment transcriptomic architecture in AL amyloidosis during daratumumab based therapy
    Szalat, Raphael
    Talluri, Srikant
    Wong, Sherry
    Morgan, Gareth
    Sanchorawala, Vaishali
    Munshi, Nikhil
    Samur, Mehmet
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S176 - S176
12345